{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:21:11Z","timestamp":1761765671564},"reference-count":7,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1097\/pas.0b013e31828f2322","type":"journal-article","created":{"date-parts":[[2013,6,22]],"date-time":"2013-06-22T14:36:00Z","timestamp":1371911760000},"page":"1407-1412","source":"Crossref","is-referenced-by-count":17,"title":["Loss of Foxp3 Is Associated With CD30 Expression in the Anaplastic Large Cell Subtype of Adult T-cell Leukemia\/Lymphoma (ATLL) in US\/Caribbean Patients"],"prefix":"10.1097","volume":"37","author":[{"given":"Jinjuan","family":"Yao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan R. S.","family":"Gottesman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Getinet","family":"Ayalew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert S.","family":"Braverman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constantine A.","family":"Axiotis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-15-20210131","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","article-title":"Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87).","volume":"79","author":"Shimoyama","year":"1991","journal-title":"Br J Haematol"},{"key":"R3-15-20210131","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/j.1349-7006.2007.00456.x","article-title":"Pathological features of diseases associated with human T-cell leukemia virus type I.","volume":"98","author":"Ohshima","year":"2007","journal-title":"Cancer Sci"},{"key":"R15-15-20210131","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s12185-011-0941-5","article-title":"Antibody therapy for adult T-cell leukemia-lymphoma.","volume":"94","author":"Ishida","year":"2011","journal-title":"Int J Hematol"},{"key":"R16-15-20210131","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2217\/imt.11.15","article-title":"Brentuximab vedotin for the treatment of CD30 lymphomas.","volume":"3","author":"Foyil","year":"2011","journal-title":"Immunotherapy"},{"key":"R17-15-20210131","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4137\/CMO.S6637","article-title":"Emerging pharmacotherapy for relapsed or refractory Hodgkins lymphoma: focus on brentuximab vedotin.","volume":"6","author":"Furtado","year":"2012","journal-title":"Clin Med Insights Oncol"},{"key":"R18-15-20210131","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/00001622-200011000-00012","article-title":"Anti-CD30 antibody-based therapy.","volume":"12","author":"Koon","year":"2000","journal-title":"Curr Opin Oncol"},{"key":"R19-15-20210131","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1345\/aph.1Q680","article-title":"Brentuximab vedotin: a new age in the treatment of Hodgkin lymphoma and anaplastic large cell lymphoma.","volume":"46","author":"Minich","year":"2012","journal-title":"Ann Pharmacother"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0b013e31828f2322","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T04:58:36Z","timestamp":1620968316000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201309000-00015"}},"subtitle":["Potential Therapeutic Implications for CD30 Antibody\u2013mediated Therapy"],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":7,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0b013e31828f2322","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}